IMVREE

Welcome to the Brand page for “IMVREE”, which is offered here for Treatment of materials, milling, grinding, mixing, compressing and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations, solutions for use in the pharmaceutical and medical industries;pharmaceutical preparations, tablets, granules, pills, sachets, powders, and capsules; all for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical and gynecological field, cancer, ophthalmoligical diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised pain;scientific research within the medical, pharmaceutical, biotechnical and bacteriological areas and providing consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; development of pharmaceutical and medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consulting and information thereto;.

Its status is currently believed to be active. Its class is unavailable. “IMVREE” is believed to be currently owned by “VELOXIS PHARMACEUTICALS A/S”.